Diabetic Nephropathy – Pathophysiology: An Overview

Background: Diabetic nephropathy (DN) is one of the commonest etiologies for ESRD. Various studies suggest that diabetic nephropathy occurs due to the accumulation of advanced glycosylated end products (AGEs), the activation of isoforms of protein C kinase, etc. Correlation of renal arterial fl ow resistance, GFR, and progression towards ESRD in DN is not well narrated in literature. Therefore, the main object of the study was to assess renal arterial fl ow resistance in patients with DN and to compare it with patients having non-evident diabetic nephropathy. Methods: This is a case control study done in a retrospective manner in the central part of Rajasthan, India, based upon data collection of admitted patients. Arbitrarily, a record of 40 cases (all males) consisting of poorly controlled diabetic cases (Hba1C >10 %) without nephropathy (n=20, group A) was compared with records of diabetic cases with nephropathy (n=20, group B). Group B had been further subdivided according to CKD (chronic kidney disease) staging. Data were examined for vital parameters, Serum creatinine, eGFR, R.I. (resistive index) in renal arterial Doppler, urine albumin. Results: Group A and group B were characteristically the same. In group B 7 cases had CKD 1(B1), 2 cases had CKD 2 (B2), 4 cases had CKD 3 (B3) and 7 cases had CKD 5(B5) stage. In group B there was a progressive rise in R.I. index parallel to decline in GFR, rise in albuminuria from B1 to B5 stage (p<0.001). These parameters were normal in group A. Conclusion: It is concluded that DN begins from an increase in resistance to fl ow in renal arteries primarily resulting from resistance in afferent arterioles due to the reduction in size. This reduction may be because of increased ACE/ basal sympathetic activity at the beginning. Later on, there is a further increase in resistance due to progressive deposition of AGE end products in afferent arterioles further reducing the size and hydrostatic pressure at the afferent arteriolar end, resulting in a progressive decrease in GFR. Simultaneously hypo-perfusion of kidney tissue activates the renin-angiotensin system further reduces fl ow and progresses the DN. Research Article Diabetic Nephropathy – Pathophysiology: An Overview Tarun Saxena1* Garima Khichi2, Ashutosh Saxena3, Ramakant Goyal2 and Nitasha Salem4 1M.D, Senior Consultant Internal Medicine, Mittal Hospital and Research Centre, Pushkar Road, Ajmer 305001, Rajasthan, India 2M.D, Senior consultant Radiodiagnosis, Mittal Hospital and Research Centre, Pushkar Road, Ajmer 305001, Rajasthan, India 3M.B.B.S. Student, Mittal Hospital and Research Centre, Pushkar Road, Ajmer 305001, Rajasthan, India 4M.B.B.S. Resident Doctor, Mittal Hospital and Research Centre, Pushkar Road, Ajmer 305001, Rajasthan, India Received: 01 April, 2019 Accepted: 21 June, 2019 Published: 22 June, 2019 *Corresponding author: Tarun Saxena, M.D, Senior Consultant Internal Medicine, Mittal Hospital and Research Centre, Pushkar Road, Ajmer 305001, Rajasthan, India, Tel: +919829089284; Fax: +91 145 2603608; E-mail: https://www.peertechz.com


Introduction
Globally incidence of ESRD (end-stage renal disease) is rising [1]. One of the commonest etiologies for ESRD is diabetic nephropathy [2]. Therapy is directed towards prevention by improving glycemic control, blood pressure control and use of ACE (angiotensin-converting enzyme) inhibitors [3][4][5]. Clinically it starts from microalbuminuria to reduction in GFR (glomerular fi ltration rate) and an overt increase in urea/ creatinine levels [6,7]. Various studies suggest that diabetic nephropathy occurs due to the accumulation of advanced glycosylated end products (AGEs), the activation of isoforms of protein C kinase and activation of the aldose reductase pathway [8]. Endothelial dysfunction is also associated with the development of DN (diabetic nephropathy) [9,10]. A few studies have suggested that complications of diabetic nephropathy are related to atherosclerosis of intrarenal and extrarenal arteries [11]. This study focuses upon measurement of intrarenal arterial fl ow resistance in DN, (indirectly suggestive of afferent arteriolar fl ow) its correlation with GFR/ CKD staging, and the possible mechanism (steps) towards progression to ESRD, and to compare it with patients having poor glycemic control along with non-evident nephropathy and therapy aspect related to pathology.

Statistical analysis
Statistical analysis was done with the help of SPSS 20.0 software by applying the appropriate test of signifi cance. (Chisquare test).

Discussion
Diabetic nephropathy (DN) is one of the commonest causes of end-stage renal disease (ESRD). Optimal therapy includes prevention by improving glycemic control, blood pressure control, use of ACE inhibitors and ARBs (angiotensin receptor blockers). Before the onset of overt proteinuria, there are multiple renal functional changes including renal hyperfi ltration, hyperperfusion and increased permeability to macromolecules.
About pathogenesis, previous studies have demonstrated, that diabetic nephropathy occurs as a result of the complex interaction of metabolic (Glucose, AGE, polyols) and hemodynamic factors (RAS, Endothelin) in renal microcirculation. There is an accumulation of advanced glycosylated end products (AGEs), the activation of isoforms of protein C kinase and activation of aldose reductase pathway, increased activity of the renin-angiotensin activity also plays an important role in the progression of the disease. Other factors including excess accumulation of extracellular protein, podocyte abnormality, albuminuria, and oxidative stress have also been implicated in DN [24][25][26][27][28]. Endothelial dysfunction is closely associated with the development of DN [29].
Clinically it starts from microalbuminuria to reduction in GFR and an overt increase in urea and creatinine levels. A few studies have suggested that complications of diabetic nephropathy are related to atherosclerosis of intrarenal and extrarenal arteries. This study focuses upon measurement of intrarenal arterial fl ow resistance, (indirectly suggestive of afferent arteriolar fl ow) in different stages of CKD and to compare it with patients having poor glycemic control with non-evident nephropathy and to fi nd possible mechanism (steps) towards progression to ESRD, and to look for some therapy aspect related to pathology.
Assessment of fl ow in intra-renal arteries was done with Renal Arterial Doppler [15,16].
The study was done in a case control, retrospective manner through data collection in Mittal hospital and research center, Pushkar Road Ajmer, Rajasthan, India. Hospital record of 40 cases (20 diabetic cases without nephropathy (control, group A) and 20 diabetic cases with the nephropathy (study group, group B) admitted between July 2016 and July 2018 was observed. We divide the discussion into four parts-1) Findings of the study 1a) Diabetic cases not having nephropathy (Group A) In long-standing diabetic cases (>5 years); HbA1C > 10 %, the cases were not associated with albuminuria; R.I. index was normal (<0.7) ( Figure 1); e-GFR normal ( Table 2).         2b) Increase in R.I. index (resistance to fl ow) is associated with decrease in GFR. This decrease is a progressive i.e. reduction in GFR from CKD stage 1 to CKD stage 5; parallel to a progressive rise in R.I. index, urea, creatinine levels. Findings suggest that the R.I. index is inversely related to GFR. GFR=1/R.I. index (CKD 2, 3, 5) (except stage 1 where damage to endothelium is evident from albuminuria but GFR is normal or may be high because of glycosuria) [31,32]. 2c) Normal R.I. index in patients with a long-standing disease without nephropathy suggests that no resistance to fl ow is associated with normal kidney functions. 2d) Increase in R.I. index starts at the earliest i.e. at albuminuria without an increase in urea/creatinine values ( Table 2).

3) Determinants of the GFR in physiology and its correlation with the current study-
3a) The GFR is determined by (a) the sum of the hydrostatic and colloid osmotic forces across the glomerular membrane, which gives the net fi ltration pressure, and (b) the glomerular capillary fi ltration coeffi cient, K f . The GFR equals the product of K f and the net fi ltration pressure: The net fi ltration pressure represents the sum of the hydrostatic and colloid osmotic forces that either favor or oppose fi ltration across the glomerular capillaries. These forces includes (A) hydrostatic pressure inside the glomerular capillaries depends upon pressure at afferent arteriolar end(glomerular hydrostatic pressure PG), which promotes fi ltration (B) the hydrostatic pressure in Bowman's capsule (PB) outsides the capillaries, which opposes fi ltration; (C) the colloid osmotic pressure of the glomerular capillary plasma proteins (πG), which opposes fi ltration; and (D) the colloid osmotic pressure of the proteins in Bowman's capsule (πB), which promotes fi ltration. The GFR is expressed as: [33][34][35][36][37]. Net fi ltration = 60 -18 -32 = +10mmHg K f represents hydraulic conductivity and surface area of the glomerular capillaries for fi ltration. The effect of all these in DN will be explained by Bernoulli's principle.

3b) Bernoulli's Principle
Bernoulli's principle says that a rise (fall) in pressure in a fl owing fl uid must always be accompanied by a decrease (increase) in speed, and conversely, is an increase (decrease) in, the speed of the fl uid results in a decrease (increase) in the pressure [34]. Reduction in afferent arteriolar diameter is associated with increased speed and hence a reduction in hydrostatic pressure at the afferent arteriolar end. 4) Possible mechanism of reduction in GFR (Co-relation between observed fi ndings and facts in physiology).
Normally, the main determinant of GFR is hydrostatic pressure (60 mmHg) at afferent arteriole/ afferent end of the capillary. In our fi nding, there is a progressive increase in resistance (R.I. index) to fl ow at the afferent arteriolar end associated with a reduction in hydrostatic pressure, parallel to a decrease in e-GFR (Figures 6,7). This increase in the RI index is due to a decrease in afferent arteriolar diameter due to persistently increased ACE activity/ increased basal sympathetic discharge in the beginning and deposition of AGE end products/arteriosclerosis [38][39][40]    Evidence of diffuse hypo-perfusion is also suggested by perfusion scan. Previous MRI scans have suggested the hypoperfusion of kidneys in DN [33,34]. Which in turn activates RAAS (renin-angiotensin aldosterone system) worsens the situation further. A vicious circle is formed i.e. deposition of AGE products-hypo perfusion-increased RAAS activityfurther vasoconstriction-poor control of DM-further AGE deposition ultimately signifi cant reduction in GFR and leads to ESRD [41][42][43][44] (Flow chart 1).

Conclusion
It is concluded that DN begins from an increase in resistance to fl ow in renal/intrarenal arteries primarily resulting from resistance in afferent arterioles due to a reduction in size [31,32]. This is depicted by progressive increase in RI index parallel to reduction in GFR. Activation of RAAS further leads to progression towards ESRD.

Suggestions
Besides available methods for treatment of DN, all attempts must be done to try to reduce resistance/improvement in fl ow in renal vasculature to improve GFR by using ACE inhibitors/ ARBS/Beta blockers. A strong strategy to inhibit AGE by strict blood glucose control and for AGE removal from afferent arterioles either by diet or drugs which seems to be the key step in preventing/treating DN.